TY  - JOUR
AU  - Fernandez-Espejo, Emilio
AU  - Rodriguez-de-Fonseca, Fernando
AU  - Gavito, Ana Luisa
AU  - Cordoba-Fernandez, Antonio
AU  - Chacon, Jose
AU  - Martin-de-Pablos, Angel
PY  - 2022
DO  - 10.3390/antiox11061088
SN  - 2076-3921
UR  - http://hdl.handle.net/10668/20783
T2  - Antioxidants (Basel, Switzerland)
AB  - Background: Myeloperoxidase (MPO) and advanced oxidation protein products, or AOPP (a type of MPO-derived chlorinated adducts), have been implicated in Parkinson´s disease (PD). Human MPO also show sex-based differences in PD. The objective was to...
LA  - en
PB  - MDPI
KW  - Parkinson’s disease
KW  - Advanced oxidation protein products
KW  - Cerebrospinal fluid
KW  - Duration
KW  - Myeloperoxidase
KW  - Blood-Brain Barrier
KW  - Advanced Oxidation Protein Products
KW  - Serum
KW  - Parkinson Disease
KW  - Brain
KW  - Peroxidase
KW  - Biomarkers
TI  - Myeloperoxidase and Advanced Oxidation Protein Products in the Cerebrospinal Fluid in Women and Men with Parkinson's Disease.
TY  - research article
VL  - 11
ER  -